Literature DB >> 9346320

Lipopolysaccharides of Helicobacter pylori serogroups O:3 and O:6--structures of a class of lipopolysaccharides with reference to the location of oligomeric units of D-glycero-alpha-D-manno-heptose residues.

G O Aspinall1, M A Monteiro, R T Shaver, L A Kurjanczyk, J L Penner.   

Abstract

Lipopolysaccharides (LPS) from antigenically different strains assigned to serogroups O:3 and O:6 of Helicobacter pylori were isolated as water-soluble material of high Mr and as water-insoluble gels of low Mr. Chemical and spectroscopic analyses of the soluble LPS and oligosaccharides liberated from the water-insoluble gels led to proposed structures with Lewis (Le) antigen determinants terminating regular repeating units of different types, linked in turn to inner core regions of invariable structure. The O:6 LPS has two populations of related molecules with chains of 3-linked D-glycero-alpha-D-manno-heptose residues similar to those in the MO19 strain, one with and the other without a single terminal Lewis (Le(y)) epitope. In contrast, in the O:3 LPS, Lewis (Le(x) and Le(y)) epitopes terminate a partially fucosylated N-acetyllactosaminoglycan, but a heptan chain similar to that in the O:6 LPS was shown to connect the outer chains to the inner core. These LPS provide examples of the molecular mimicry of cell-surface glycoconjugates. Structural variations of LPS between strains, and differences in some aspects of structure within strains, between high Mr and low Mr LPS indicate a class of LPS whose mechanisms of biosynthesis lead to overall architectures different from those characteristic of most LPS from enteric bacteria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346320     DOI: 10.1111/j.1432-1033.1997.00592.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Helicobacter pylori specific immune response induced by conservative flagellin linear B-cell epitope.

Authors:  Wan-Sheng Ji; Jia-Lu Hu; Kai-Chun Wu; Jun-Wen Qiu; Zhe-Yi Han; Jie Ding; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  A novel 3-deoxy-D-manno-octulosonic acid (Kdo) hydrolase that removes the outer Kdo sugar of Helicobacter pylori lipopolysaccharide.

Authors:  Christopher Stead; An Tran; Donald Ferguson; Sara McGrath; Robert Cotter; Stephen Trent
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

3.  Polymorphism of flagellin A gene in Helicobacter pylori.

Authors:  W S Ji; J L Hu; J W Qiu; D R Peng; B L Shi; S J Zhou; K C Wu; D M Fan
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  Two distinct antigenic types of the polysaccharide chains of Helicobacter pylori lipopolysaccharides characterized by reactivity with sera from humans with natural infection.

Authors:  S I Yokota; K I Amano; Y Shibata; M Nakajima; M Suzuki; S Hayashi; N Fujii; T Yokochi
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

5.  Phase variation in Helicobacter pylori lipopolysaccharide.

Authors:  B J Appelmelk; B Shiberu; C Trinks; N Tapsi; P Y Zheng; T Verboom; J Maaskant; C H Hokke; W E Schiphorst; D Blanchard; I M Simoons-Smit; D H van den Eijnden; C M Vandenbroucke-Grauls
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN.

Authors:  Mathijs P Bergman; Anneke Engering; Hermelijn H Smits; Sandra J van Vliet; Ad A van Bodegraven; Hans-Peter Wirth; Martien L Kapsenberg; Christina M J E Vandenbroucke-Grauls; Yvette van Kooyk; Ben J Appelmelk
Journal:  J Exp Med       Date:  2004-10-18       Impact factor: 14.307

Review 7.  Lipopolysaccharide Structural Differences between Western and Asian Helicobacter pylori Strains.

Authors:  Hong Li; Hong Tang; Aleksandra W Debowski; Keith A Stubbs; Barry J Marshall; Mohammed Benghezal
Journal:  Toxins (Basel)       Date:  2018-09-08       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.